Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Receives Support from Allergy & Asthma Network
September 13, 2019 09:05 ET | Intrommune Therapeutics
New York, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing the patient-friendly oral mucosal immunotherapy (OMIT) toothpaste platform for...
Intrommune Logo Only - 250k.jpg
Newly Published Findings Validate Intrommune’s Approach to Treating Peanut and Other Food Allergies
September 05, 2019 15:20 ET | Intrommune Therapeutics
New York, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly immunotherapy platform for the treatment of peanut and...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Receives Formulation Patent Notice of Allowance
August 21, 2019 14:41 ET | Intrommune Therapeutics
New York, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
MN Health Fairs.jpg
Health Fair 11 at the Fair Offers Healthy Options to State Fair Goers
August 15, 2019 17:35 ET | Minnesota Health Fairs Inc.
GOLDEN VALLEY, Minn., Aug. 15, 2019 (GLOBE NEWSWIRE) -- The Minnesota State Fair is all about tradition. Fairgoers have their must-eat food(s!), their tried-and-true route around the fairgrounds,...
Food Allergies Are Top Concern for Families As They Prepare for Back-to-School
August 15, 2019 08:21 ET | Asthma and Allergy Foundation of America
Washington, D.C., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Today, the Asthma and Allergy Foundation of America (AAFA) released a report of findings from its “My Life With Food Allergy” study. As children...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Receives Best Private Company Presentation Award at BioNJ’s 9th Annual BioPartnering Conference
May 17, 2019 13:25 ET | Intrommune Therapeutics
New York, May 17, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing patient-friendly food allergy therapies for peanut and other food allergies...
Quick Umbrellux DAO Test Reveals If That Reaction Is Really Histamine Intolerance And Not A Food Allergy
May 13, 2019 09:30 ET | Umbrellux DAO
ANN ARBOR, Mich., May 13, 2019 (GLOBE NEWSWIRE) -- Food Allergy Awareness Week is the perfect time to determine if you may be mislabeling your body’s reaction to certain foods. Umbrellux DAO offers...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy
March 08, 2019 10:01 ET | Intrommune Therapeutics
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...
USBioTekLogo.png
US BioTek Laboratories Announces Jack Frausing as CEO
January 14, 2019 08:00 ET | US BioTek
SEATTLE, Jan. 14, 2019 (GLOBE NEWSWIRE) -- US BioTek Laboratories (US BioTek) announced today the appointment of a new President and CEO, Jack Frausing. Frausing assumes the leadership from...
Intrommune Logo Only - 250k.jpg
Intrommune Therapeutics Announces First Close of Series A Preferred Equity Financing and Successful Close of Crowdfunding Financing Campaign to Support New Peanut Allergy Treatment
November 08, 2018 16:44 ET | Intrommune Therapeutics
New York, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is...